L. Resnick

发表

Contributions of academic laboratories to the discovery and development of chemical biology tools.

Peter Wipf, Donna M Huryn, P. Wipf, 2013, Journal of medicinal chemistry.

Targeting JNK3 for the treatment of neurodegenerative disorders.

M. Fennell, L. Resnick, 2004, Drug discovery today.

HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines.

G. M. Wilson, P. Wipf, J. Grandis, 2015, Assay and drug development technologies.

Contributions of Academic Labs to the Discovery and Development of Chemical Biology Tools

P. Wipf, D. Huryn, L. Resnick, 2013 .

Synthesis and structure–activity relationships of small molecule inhibitors of the simian virus 40 T antigen oncoprotein, an anti-polyomaviral target.

P. Wipf, J. Pipas, J. Brodsky, 2014, Bioorganic & medicinal chemistry.

De novo synthesis of teleocidin B analogs

A. Gilbert, Kangwen Deng, J. Butera, 2010 .

Synthesis of the liposidomycin diazepanone

S. Nandan, S. Knapp, L. Resnick, 1992 .

Species‐specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers

B. Bingham, L. Resnick, J. Kennedy, 2007, British journal of pharmacology.

First Total Synthesis of a Pyripyropene‐Type ACAT Inhibitor, (.+‐.)‐ GERI‐BP001.

L. Resnick, K. A. Parker, 1996 .

THE FIRST TOTAL SYNTHESIS OF A PYRIPYROPENE-TYPE ACAT INHIBITOR, ()-GERI-BP001

L. Resnick, K. A. Parker, 1995 .

N,N‐Dimethylacetamide Dimethyl Acetal

David R. Williams, L. Resnick, K. A. Parker, 2009 .

N,N‐Dimethylpropionamide Dimethyl Acetal

L. Resnick, K. A. Parker, 2001 .

A practical synthesis of 3-ethyl-l-norvaline

L. Resnick, R. Galante, 2006 .

Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2).

K. Parris, J. Telliez, F. Lovering, 2009, Bioorganic & medicinal chemistry.

Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.

T. Comery, K. Fan, B. Harrison, 2008, Journal of medicinal chemistry.

Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist

K. Marquis, S. Grauer, Radka Graf, 2010, Neuropharmacology.

Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism.

L. Leventhal, C. Beyer, J. Dwyer, 2010, The international journal of neuropsychopharmacology.

Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease

D. Lo, P. Reinhart, W. Hirst, 2010, Neurobiology of Disease.

2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.

P. Wipf, J. Grandis, D. Huryn, 2014, Bioorganic & Medicinal Chemistry Letters.

Practical asymmetric synthesis of a novel γ-secretase inhibitor

Zheng Wang, L. Resnick, 2008 .

Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.

B. Harrison, D. Huryn, K. Atchison, 2009, Bioorganic & medicinal chemistry.

2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.

P. Wipf, J. Grandis, D. Huryn, 2014, Bioorganic & medicinal chemistry letters.